IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.
External link for IBA
IBA Proton Therapy teams just concluded their commercial kickoff meeting in Cely, France. It was the perfect opportunity to come together and discuss strategic vision for advancing proton therapy.
We just wrapped up an incredible commercial kickoff meeting in Cely, France! It was an inspiring event where we discussed our vision and strategies to advance proton therapy. Let’s bridge the proton therapy gap and make it accessible to all patients who could benefit from it. 🌍💪 #letsbridgethegap
🎓Join IBA at your school's Job Fair! Discover exciting career opportunities and learn about life at IBA. Whether you're seeking a job, internship, or student position, come chat with us! 👉 Curious about our job offers? Check IBA's career site: https://lnkd.in/dZASwi2R We can't wait to meet you!
On this International Day of Women and Girls in Science, IBA honors the women who are driving the future of science. Check out the inspiring mottos shared by our IBA RadioPharma Solutions colleagues 👇 #WomenInScience #InternationalDayOfWomenInScience
👩🔬 𝗪𝗼𝗺𝗲𝗻 𝗶𝗻 𝗦𝗰𝗶𝗲𝗻𝗰𝗲: 𝗜𝗻𝘀𝗽𝗶𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗡𝗲𝘅𝘁 𝗚𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 🔬 Today, on the International Day of Women in Science, we celebrate the brilliant minds of women shaping the future of science. At IBA RadioPharma Solutions, our amazing women working in science share the mottos that drive them and fuel their passion - words they wish they had heard when they started their studies. 🎬 𝗕𝗲 𝗶𝗻𝘀𝗽𝗶𝗿𝗲𝗱 𝗯𝘆 𝘁𝗵𝗲𝗶𝗿 𝗽𝗮𝘀𝘀𝗶𝗼𝗻 Don't miss their full interviews, which will be shared on our Instagram account and website throughout the week. https://lnkd.in/e3fSEkTp https://lnkd.in/gvWqUPD #WomenInScience #InternationalDayOfWomenInScience #IBACommunity Cristiana Gameiro Elena Sperotto Magdalena Rodak Noémie Emmanuel Anne Royer Moës Sujala Vaniyath
📢 Press release Framatome and IBA RadioPharma Solutions have signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (²¹¹At), an alpha-emitting radioisotope across Europe and the United States. 🔗 Read the full press release here: https://lnkd.in/eim5egss
📣𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗙𝗿𝗮𝗺𝗮𝘁𝗼𝗺𝗲 𝗮𝗻𝗱 𝗜𝗕𝗔 𝘁𝗼 𝗽𝗮𝗿𝘁𝗻𝗲𝗿 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝗮𝗻 𝗔𝘀𝘁𝗮𝘁𝗶𝗻𝗲-𝟮𝟭𝟭 𝗖𝘆𝗰𝗹𝗼𝘁𝗿𝗼𝗻 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗨𝗦𝗔 We are delighted to announce that IBA and Framatome signed a Memorandum Of Understanding to start a strategic partnership aimed at advancing industrial-scale production of Astatine-211 (²¹¹At), an alpha-emitting radioisotope across Europe and the United States. Charles Kumps, President of IBA RadioPharma Solutions: "It is the start of what we believe will be a strong partnership with a shared goal: building a global, reliable industrial network for the timely production and commercialization of Astatine-211 compounds. By leveraging our combined expertise in cyclotron technology and in nuclear medicine, we are creating the critical infrastructure necessary to unlock the full potential of these groundbreaking therapies.” 👉 Read the Press Release → https://bit.ly/42HCejr #IBA #Astatine211 #TAT #radioisotope #Theranostic #Alpha
📢 Press release IBA Proton Therapy has signed an agreement with the Asian Institute of Gastroenterology for the supply of a Proteus®ONE at the new Oncology Centre within AIG Hospitals’ Gachibowli campus in Hyderabad, India. 🔗Read the full press release here: https://lnkd.in/dWRigKmZ
🌍 On this World Cancer Day, IBA reaffirms its unwavering support for all those affected by this disease. We are proud to contribute to the fight against cancer through our innovative treatment and diagnostic solutions. #WorldCancerDay
At IBA Proton Therapy, we are committed to advancing cancer treatment and improving patient outcomes. On this 𝗪𝗼𝗿𝗹𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 🌍, we stand united with the global community in the 𝗳𝗶𝗴𝗵𝘁 𝗮𝗴𝗮𝗶𝗻𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿. Proton therapy offers a precise and effective treatment option, minimizing side effects and improving the quality of life for patients (1,2). 𝗟𝗲𝘁’𝘀 𝗯𝗿𝗶𝗱𝗴𝗲 𝘁𝗵𝗲 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗴𝗮𝗽 and ensure that more patients have access to this innovative technology. Join us in raising awareness and supporting cancer patients worldwide. Together, we can make a difference. 1. Baumann BC, et al. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. JAMA Oncol. 2020;6(2):237-246. 2. Mohan R and Grosshans D. Proton therapy - Present and future. Adv Drug Deliv Rev. 2017;109:26-44.
Meet our experts from IBA RadioPharma Solutions, IBA Industrial Solutions, IBA Proton Therapy and IBA Dosimetry at #ArabHealth2025. Visit them from January 27 to 30 at booth S1.F10 in Dubai.
𝗠𝗲𝗲𝘁 𝘂𝘀 𝗮𝘁 𝗔𝗿𝗮𝗯 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝘁 𝗯𝗼𝗼𝘁𝗵 𝗦𝟭.𝗙𝟭𝟬! 👥 Meet our leading experts who are ready to discuss your radioisotopes' needs and provide you with insights into the latest innovations in the field. 🔍 Discover our custom-designed cyclotrons and integrated solutions, tailored for your radiopharmaceuticals needs. #ArabHealth2025 #radiopharmaceuticals #cyclotron #radioisotopes Robert Kwizera, Peter Leitner, Ambrosio Moreno, Frederic Jodocy, Feltz FX, Pauline Sevrin, Evelyne Loriaux
📢 Press release IBA and WE International announce a joint strategic investment of EUR 5 million each in mi2-factory GmbH, a start-up and spin-off from the University of Applied Sciences Jena, Germany. This investment secures a 15% stake for IBA and a 15% stake for WE International. 🔗 Read the full press release here: https://lnkd.in/eCvkRmhe
📢 Press release IBA announces Chief Financial Officer transition. Soumya Chandramouli will be stepping down from her role as CFO, effective 31 January 2025. Henri de Romrée, Deputy CEO, will oversee the financial direction at Group level until a new CFO has been appointed. 🔗 Read the full press release here: https://lnkd.in/ddJisRT2
“𝑊ℎ𝑎𝑡 𝐼 𝑙𝑖𝑘𝑒 𝑚𝑜𝑠𝑡 𝑎𝑏𝑜𝑢𝑡 𝑚𝑦 𝑗𝑜𝑏 𝑖𝑠 𝑏𝑒𝑖𝑛𝑔 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡𝑙𝑦 𝑐ℎ𝑎𝑙𝑙𝑒𝑛𝑔𝑒𝑑.” Kick off 2025 with inspiration from Stephanie's journey. 🌟 Discovering IBA was a turning point for her. She immediately felt at home. She was touched by her colleagues' warmth and the recruiters' belief in her. In her role, she gets to take on new challenges every day while giving her best. 👉 Ready for your next move? Explore our career site and see what’s waiting for you! https://lnkd.in/dZASwi2R